- Business Wire•3 days agoCyanotech® Corporation Earns Non-GMO Project Verification for BULK SCE BioAstin® Natural Astaxanthin Products
Cyanotech® Corporation , is proud to announce that its bulk raw material BioAstin® SCE products have received Non-GMO Project Verification. BioAstin Natural Astaxanthin is a potent natural antioxidant that provides natural support for joint, skin, eye and brain health.* BioAstin is derived from natural microalgae, Haematococcus pluvialis, cultivated and grown on the Kona coast of the Big Island of ...
- American City Business Journals•last month
Cyanotech Corp. (Nasdaq Capital Market: CYAN), a Kailua-Kona-headquartered maker of microalgae-based nutrition and health products, announced Tuesday that it had a net loss of $691,000, or 12 cents per diluted share, during its first quarter of fiscal year 2017 compared with a net loss of $105,000, or 2 cents per diluted share, for the first quarter of FY 2016. Net sales were $7.32 million for the most-recent quarter compared with $7.59 million, a decrease of 3.6 percent.
- Business Wire•last month
Cyanotech Corporation , a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the first quarter of fiscal year 2017, ended June 30, 2016.
Cyanotech Corp. (CYAN)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||3.66 x 200|
|Ask||3.90 x 500|
|Day's Range||3.66 - 3.66|
|52wk Range||3.32 - 6.14|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-4.11|
|Avg Vol (3m)||4,229|
|Dividend & Yield||N/A (N/A)|